Dermaclear Mask

Description

Manufactured for DermaQuest®, Inc., located in Hayward, California, this product is produced in the USA. The company’s website is dermaquestinc.com.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects mentioned associated with the use of this medication.

Dosage and Administration

Healthcare professionals are advised to apply a thin layer of the product to the affected areas after cleansing the skin with fingertips. The application should be followed by gentle massage in circular movements for a duration of 1 to 2 minutes. It is important to allow the product to remain on the skin for 5 to 10 minutes, adjusting the time based on the patient's skin tolerance and sensitivity.

After the designated time, the product should be rinsed off thoroughly. Following the rinse, it is recommended to adhere to the suggested post-mask home care regimen to optimize treatment outcomes.

Contraindications

Use is contraindicated in patients with very sensitive skin due to the potential for adverse reactions.

Warnings and Precautions

For external use only. This product is not intended for internal use, and ingestion may lead to serious health consequences. In the event of accidental swallowing, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Caution is advised for individuals with very sensitive skin. The use of this product in such cases may lead to adverse reactions. Healthcare professionals should assess the patient's skin sensitivity prior to recommending this product.

Patients should be instructed to discontinue use and consult a physician if severe skin irritation develops. Additionally, concurrent use with other topical medications should be avoided unless directed by a healthcare provider, as this may increase the risk of skin irritation or other adverse effects.

Side Effects

Patients should be advised that the product is for external use only. In the event of severe skin irritation, it is recommended to discontinue use and consult a healthcare professional. Additionally, caution should be exercised when using this product concurrently with other topical medications, as this may exacerbate skin irritation or lead to other adverse reactions.

Drug Interactions

Concurrent use of other topical acne medications or topical treatments may lead to increased dryness or irritation of the skin. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional.

Additionally, the simultaneous application of other topical medications may result in severe skin irritation. Therefore, careful consideration should be given to the use of multiple topical agents, and monitoring for signs of irritation is recommended.

Packaging & NDC

Below are the non-prescription pack sizes of Dermaclear Mask (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or a Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of DERMACLEAR MASK (salicylic acid cream) during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks versus benefits before prescribing this product to pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the situation effectively.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for guiding treatment decisions and ensuring patient safety.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed not to use this product if they have very sensitive skin, as it may exacerbate their condition. When using this product, it is crucial to avoid contact with the eyes, lips, and mouth to prevent irritation.

Additionally, healthcare providers should counsel patients on the potential for increased dryness or irritation of the skin when using this product in conjunction with other topical acne medications. If such reactions occur, patients should be instructed to use only one medication unless otherwise directed by a healthcare professional.

Finally, patients should be made aware of the importance of sun protection. If they are sensitive to the sun or anticipate increased sun exposure, they should use a sunscreen to mitigate the risk of adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dermaclear Mask, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)